Director Cynthia Feldmann of STERIS (STE) exercises options and sells 3,098 shares

Q: What insider transactions did STERIS (STE) director Cynthia Feldmann report?

Cynthia L. Feldmann reported exercising options into 3,098 ordinary shares and then selling 3,098 shares in an open‑market transaction. The filing also shows she continues to hold shares both directly and indirectly through a revocable trust.

Q: How many STERIS (STE) shares did Cynthia Feldmann sell in this Form 4?

The Form 4 shows Cynthia L. Feldmann sold 3,098 ordinary shares of STERIS plc in an open‑market transaction. The sale was executed at a weighted average price of $237.21 per share , based on multiple trades within a narrow price range.

Q: How many STERIS (STE) shares does Cynthia Feldmann own after the reported transactions?

After the reported transactions, Cynthia L. Feldmann holds 705 ordinary shares directly. The Form 4 also reports 8,663 ordinary shares held indirectly in a revocable trust, where she and her husband serve as trustees, indicating additional indirect ownership.

Q: At what price were Cynthia Feldmann’s STERIS (STE) shares sold?

The reported sale of 3,098 STERIS ordinary shares was executed at a weighted average price of $237.21 per share . Footnotes state that individual trades occurred between $237.16 and $237.33 per share, and full trade details are available upon request.

Q: How are Cynthia Feldmann’s indirect STERIS (STE) holdings structured?

The Form 4 reports 8,663 ordinary shares held indirectly in a revocable trust. A footnote explains that these shares are held in a trust where Cynthia L. Feldmann and her husband act as trustees, reflecting beneficial ownership through this structure.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

STERIS plc director Cynthia L. Feldmann exercised stock options and sold shares in a same‑day transaction. She exercised options for 3,098 ordinary shares through a derivative conversion, then acquired the same number of ordinary shares at a price of $152.32 per share. She subsequently sold 3,098 ordinary shares in an open‑market transaction at a weighted average price of $237.21 per share, leaving 705 ordinary shares held directly. In addition, 8,663 ordinary shares are held indirectly in a revocable trust for which Ms. Feldmann and her husband serve as trustees.

Insider Trade Summary

Net Seller: 3,098 shares ($734,877)

Net Sell 4 txns

Insider FELDMANN CYNTHIA L

Role Director

Sold 3,098 shs ($735K)

Type	Security	Shares	Price	Value
Exercise	Director Stock Option (right to buy)	3,098	$0.00	--
Exercise	Ordinary Shares	3,098	$152.32	$472K
Sale	Ordinary Shares	3,098	$237.21	$735K
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Director Stock Option (right to buy) — 0 shares (Direct); Ordinary Shares — 3,803 shares (Direct); Ordinary Shares — 8,663 shares (Indirect, See Footnote Below)

Footnotes (1)

Price reflects a weighted average sale price for multiple transactions ranging from $237.16 to $237.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. These ordinary shares are held in a revocable trust, with Ms. Feldmann and her husband as Trustees. These nonqualified stock options are fully vested and are exercisable immediately.

Form 4 Insider Transactions: What Each Field Means →

03/06/2026 - 04:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FELDMANN CYNTHIA L

(Last)

(First)

(Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2

D02 R296

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	03/05/2026		M		3,098	A	$152.32	3,803	D
Ordinary Shares	03/05/2026		S		3,098	D	$237.21⁽¹⁾	705	D
Ordinary Shares								8,663	I	See Footnote Below⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Director Stock Option (right to buy)	$152.32	03/05/2026		M			3,098	⁽³⁾	08/06/2029	Ordinary Shares	3,098	$0	0	D

Explanation of Responses:

1. Price reflects a weighted average sale price for multiple transactions ranging from $237.16 to $237.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

2. These ordinary shares are held in a revocable trust, with Ms. Feldmann and her husband as Trustees.

3. These nonqualified stock options are fully vested and are exercisable immediately.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did STERIS (STE) director Cynthia Feldmann report?

Cynthia L. Feldmann reported exercising options into 3,098 ordinary shares and then selling 3,098 shares in an open‑market transaction. The filing also shows she continues to hold shares both directly and indirectly through a revocable trust.

How many STERIS (STE) shares did Cynthia Feldmann sell in this Form 4?

The Form 4 shows Cynthia L. Feldmann sold 3,098 ordinary shares of STERIS plc in an open‑market transaction. The sale was executed at a weighted average price of $237.21 per share, based on multiple trades within a narrow price range.

What stock option activity did Cynthia Feldmann report for STERIS (STE)?

Cynthia L. Feldmann exercised nonqualified stock options that were fully vested and immediately exercisable, converting them into 3,098 ordinary shares. The filing describes this as an exercise or conversion of a derivative security rather than an open‑market purchase of shares.

How many STERIS (STE) shares does Cynthia Feldmann own after the reported transactions?

After the reported transactions, Cynthia L. Feldmann holds 705 ordinary shares directly. The Form 4 also reports 8,663 ordinary shares held indirectly in a revocable trust, where she and her husband serve as trustees, indicating additional indirect ownership.

At what price were Cynthia Feldmann’s STERIS (STE) shares sold?

The reported sale of 3,098 STERIS ordinary shares was executed at a weighted average price of $237.21 per share. Footnotes state that individual trades occurred between $237.16 and $237.33 per share, and full trade details are available upon request.

How are Cynthia Feldmann’s indirect STERIS (STE) holdings structured?

The Form 4 reports 8,663 ordinary shares held indirectly in a revocable trust. A footnote explains that these shares are held in a trust where Cynthia L. Feldmann and her husband act as trustees, reflecting beneficial ownership through this structure.